Advanced search
Publication Cover
Pediatric Hematology and Oncology Volume 29, 2012 - Issue 2
Submit an article Journal homepage
143
Views
2
CrossRef citations to date
0
Altmetric
COMMENTARY

Should We Treat Children with Down Syndrome and Leukemia in the Developing World?

Vikas DuaPediatric Hematology Oncology and Bone Marrow Transplantation Unit, Department of Pediatrics, Institute of Child Health, Sir Ganga Ram Hospital, Old Rajender Nagar, New Delhi, India
, MD,
Satya Prakash YadavPediatric Hematology Oncology and Bone Marrow Transplantation Unit, Department of Pediatrics, Institute of Child Health, Sir Ganga Ram Hospital, Old Rajender Nagar, New Delhi, IndiaCorrespondence[email protected]
, DCH, DNB &
Anupam SachdevaPediatric Hematology Oncology and Bone Marrow Transplantation Unit, Department of Pediatrics, Institute of Child Health, Sir Ganga Ram Hospital, Old Rajender Nagar, New Delhi, India
, DCH, MD
Pages 105-108 | Received 04 Sep 2011, Accepted 19 Dec 2011, Published online: 29 Feb 2012

REFERENCES

  • Jyothi A, Rao GNM, Kumar KSD, Translocation Down syndrome. Ind J Med Sci. 2002;56:225–229.
  • Robison LL. Down syndrome and leukemia. Leukemia. 1992;6:5–7.
  • Iselius L, Jacobs P, Mortan N. Leukemia and transient leukemia in Down syndrome. Hum Genet. 1990;85:477–485.
  • Sachdeva A, Jain V, Yadav SP, Move to alternative medicine why? And when? The Indian scenario [abstract]. Pediatr Blood Cancer. 2005;45:578.
  • Yadav SP, Dua V, Sachdeva A. Sepsis is a major barrier to improving survival in childhood acute lymphoblastic leukemia in the developing world. J Pediatr Hematol Oncol. 2011;33:636.
  • Yadav SP, Ramzan M, Lall M, Sachdeva A. Pediatric acute myeloid leukemia: final frontier for pediatric oncologists in developing world. Pediatr Hematol Oncol. 2011;28:647–648.
  • Gamis AS, Alonzo TA, Hilden JM. Outcome of Down syndrome (DS) children with acute myeloid leukemia (AML) or myelodysplasia (MDS) treated with a uniform prospective clinical trial-Initial report of the COG Trial A2971 [abstract]. Blood. 2006;108:A15.
  • Levitt GA, Stiller CA, Chessells JM. Prognosis of Down's syndrome with acute leukemia. Arch Dis Child. 1990;65:212–216.
  • Ravindranath Y, Abella E, Krischer JP, Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML Study 8498. Blood. 1992;80:2210–2214.
  • Taub JW, Huang X, Matherly LH, Expression of chromosome 21-localized genes in acute myeloid leukemia: differences between Down syndrome and non-Down syndrome blast cells and relationship to in vitro sensitivity to cytosine arabinoside and daunorubicin. Blood. 1999;94:1393–1400.
  • Robison LL, Nesbit MEJ, Sather HN, Down syndrome and acute leukemia in children: a 10-year retrospective survey from Children Cancer Study Group. J Pediatr. 1984;105:235–242.
  • Crombet O, Svarch E. Down syndrome and juvenile myelomonocytic leukemia. Pediatr Hematol Oncol. 1999;16:181–182.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.